rAAV2-VMD2-hMERTK

N/A

Report date: 2023/10/26 16:59:48

Base Information

Drug NamerAAV2-VMD2-hMERTK
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinal DiseasesRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySaudi Arabia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing Khaled Eye Specialist Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Khaled Eye Specialist Hospital
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A